Cell proliferation kinetics in five human solid tumors
Edmond P. Malaise, M Tubiana · Cancer · 1968
The in-vivo study of the cell cycle in human tumors with the labeled mitosis curve is possible if the choice of patient conforms to certain criteria. In four of our cases good data were obtained, T8 varied between 7 and 19 hours and Tc between 1 day and 4 days. In two of the patients the shape of the curve suggests large fluctuations of the durations of the various phases of the cell cycle. For the third patient the peak of the labeled mitosis curve never exceeds 50%; this large spread of the duration of the phases of the cell cycle within the tumor cell population may be due to previous treatment of his tumor. There is a large discrepancy between the clinical doubling time and the potential doubling time computed on the basis of Tc and GF and assuming no cell loss. This discrepancy seems to indicate that the extent of cell loss is a major parameter of the growth rate of human tumors.
Cited by 138 works. doi:10.1002/1097-0142(196809)22:3<611::aid-cncr2820220317>3.0.co;2-i Open-access PDF
Authors
References
- Cell loss as a factor in the growth rate of human tumours
- Autoradiographic Analysis of Cell Proliferation in Spontaneous Breast Cancer of C3H Mouse. III. The Growth Fraction 2
- THE RELATIONSHIP OF THE CELL CYCLE TO TUMOR GROWTH AND CONTROL OF CELL DIVISION: A REVIEW.
- Labeling of human tumor cells in vivo by tritiated thymidine.
- CELL PROLIFERATION KINETICS IN THE GASTROINTESTINAL TRACT OF MAN. I. CELL RENEWAL IN COLON AND RECTUM*
- Kinetics of cell proliferation of an experimental tumor.
- Cell proliferation in Burkitt tumours
- Cellular Radiation Biology.
- Kinetics of proliferation of cancer cells in neoplastic effusions in man
- Uptake of tritiated thymidine by human tumors in vivo.